0001209191-19-014100.txt : 20190227 0001209191-19-014100.hdr.sgml : 20190227 20190227165724 ACCESSION NUMBER: 0001209191-19-014100 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190225 FILED AS OF DATE: 20190227 DATE AS OF CHANGE: 20190227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WENTWORTH KORY JAMES CENTRAL INDEX KEY: 0001725663 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35966 FILM NUMBER: 19638540 MAIL ADDRESS: STREET 1: 60 BINNEY STREET STREET 2: C/O BLUEBIRD BIO, INC. CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: bluebird bio, Inc. CENTRAL INDEX KEY: 0001293971 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 60 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 339-499-9300 MAIL ADDRESS: STREET 1: 60 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Genetix Pharmaceuticals Inc DATE OF NAME CHANGE: 20040616 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-25 0 0001293971 bluebird bio, Inc. BLUE 0001725663 WENTWORTH KORY JAMES C/O BLUEBIRD BIO, INC. 60 BINNEY STREET CAMBRIDGE MA 02142 0 1 0 0 Principal Accounting Officer Common Stock 2019-02-25 4 S 0 208 150.0038 D 6746 D The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on December 19, 2018. The range in prices for the transaction reported on this line was $150.00 to $150.10. The average weighted price was $150.0038. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ Jason F. Cole, Attorney-in-Fact 2019-02-27